Insulin resistance and diabetes are inextricably linked to chronic hepatitis C. Our understanding of this relationship continues to improve. This review focuses on the molecular mechanisms relating insulin resistance to hepatitis C with a subsequent overview of the consequences of hepatitis C-associated insulin resistance and diabetes, as well as perspectives for future management.
- Diabetes mellitus
Statistics from Altmetric.com
All authors contributed equally to this article.
The opinion of ascertains contained herein are the private views of the authors and are not to be construed as official or reflecting the view of the Department of the Army or the Department of Defense.
Competing interests SAH: Research support from Genentech, Merck and Rottapharm; Ad Hoc Advisory Board for Three Rivers Pharmaceuticals; Speaker's bureau for Bristol Myers Squibb.
Provenance and peer review Not commissioned; externally peer reviewed.